AFIB Cardiovascular Disease Obesity 
CardiacWire
OCTOBER 27, 2024
It’s well known that heart disease is the U.S.’s s top cause of death, and our rising CVD rates have been widely covered, but a look back on some of the biggest stories of 2024 suggests that cardiovascular disease is about to become a much bigger problem. trillion, representing 4.6% If applied across the U.S., adult population.
Cardiometabolic Health Congress
DECEMBER 5, 2024
The American Heart Association (AHA) Congress 2024 , held from November 1618, marked a pivotal moment in cardiovascular and metabolic health. As the AHA celebrates its 100th year, the conference reflected on a century of innovation while exploring the future of cardiovascular disease prevention and management. View the study.
DAIC
DECEMBER 19, 2023
OSA disproportionately affects the 92 million Americans living with cardiovascular disease (CVD), often goes undiagnosed (1) , and doubles the risk for heart failure and other serious cardiovascular conditions. Western Regional Director of Cardiac Electrophysiology, Northwell Health , NY.
Cardiometabolic Health Congress
DECEMBER 7, 2023
Published on November 30, 2023, in the Journal of the American College of Cardiology, these new guidelines are based on a comprehensive literature review from May 2022 to November 2022, and provide important recommendations to clinicians caring for patients with or at risk of developing cardiovascular disease (CVD).
Dr. S. Venkatesan MD
JANUARY 1, 2025
24 and TCT 2024) Colchicine in AMI CLEAR SYNERGY (OASIS 9) (TCT 2024 and AHA 2024) Semaglutide Treatment Effect in People With Obesity and HFpEF and Diabetes Mellitus STEP-HFpEF DM (ACC.24) Top 10 Clinical Trials Preventive PCI on Stenosis With Functionally Insignificant Vulnerable Plaque PREVENT (ACC.24) Did we follow up ?
Expert insights. Personalized for you.
59 
Let's personalize your content